Skip to main content

Table 1 Baseline characteristics

From: An observational study of an adjusted patient blood management protocol intended to lower rates of transfusion following total knee arthroplasty in patients with preoperative anemia

 

ACD- (n = 683)

ACD + (n = 68)

p value

Age [years]

71.9 ± 7.9

75.9 ± 9.3

 < 0.001

Sex (Female)§

412 (60.4%)

52 (76.5%)

0.009

BMI [kg/m2]

32.2 ± 6.1

31.7 ± 6.9

0.539

Hb at the preoperative consultation [g/dl]

14.0 ± 1.2

11.3 ± 0.6

 < 0.001

Hb the day before surgery [g/dl]

13.8 ± 1.2

12.0 ± 1.0

 < 0.001

Chronic antithrombotic drug use§

269 (39.4%)

30 (44.1%)

0.102

Preoperative EPO§

1 (0.1%)

28 (41.2%)

 < 0.001

TXA use§

655 (96.0%)

67 (98.5%)

0.503

ASA§

  

0.001

- ASA 1

82 (12.0%)

1 (1.5%)

 

- ASA 2

518 (76.0%)

41 (69.1%)

 

- ASA 3

82 (12.0%)

20 (29.4%)

 

Mean corpuscular volume [fL]*

93.4 ± 4.9 (81 – 113)

91.7 ± 6.2 (77.7 – 115.5)

0.008

Preoperative MDRD [ml/mn/m2]

83.7 ± 21.5

72.3 ± 29.4

0.001

Ischemia duration [min]

50.4 ± 18.2

46.7 ± 17.6

0.113

  1. Presented as mean ± standard deviation, except * presented as mean ± standard deviation (range), § presented as number of observations (%). Abbreviations: ACD, anemic chronic disease; ASA, American Society of Anesthesiology; EPO, erythropoietin; MDRD, Modification of Diet in Renal Disease; TXA, tranexamic acid